News

Show
news from

OMass Therapeutics Adds Mark Namchuk, PhD to Scientific Advisory Board

OMass Therapeutics Expands Leadership Team with Two New Appointments

OMass Therapeutics Announces Appointment of New Board Chair and Series B Extension

OMass Therapeutics Announces New Phase of Growth with Move to New Facilities and Team Expansion to Support Portfolio Progress

Publication in Nature Chemistry Demonstrates the Benefits of Native Mass Spectrometry in the Interrogation of Target Ecosystems and Drug Discovery

OMass Therapeutics Raises $100 Million in Series B Financing to Progress Drug Pipeline in Immunology and Rare Diseases

Load more

Search